Markets:

Overview

News

Currencies

International

Treasuries

MannKind Corporation - Common Stock (NQ:MNKD)

4.005 +0.665 (+19.91%)

Streaming Delayed Price Updated: 2:42 PM EDT, Sep 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MannKind Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare Conference

August 01, 2023

From MannKind

Via GlobeNewswire

MannKind Corporation to Hold 2023 Second Quarter Financial Results Conference Call on August 7, 2023

July 31, 2023

From MannKind

Via GlobeNewswire

Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now ↗

July 13, 2023

These three worst biotech stocks are not investable even if you're bullish on the sector overall. There are better options.

Via InvestorPlace

7 Biotech Stocks to Sell in July ↗

July 13, 2023

Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.

Via InvestorPlace

Why Shares of MannKind Are Up Wednesday ↗

May 10, 2023

The company released its first-quarter earnings report on Tuesday.

Via The Motley Fool

MannKind (MNKD) Q1 2023 Earnings Call Transcript ↗

May 09, 2023

MNKD earnings call for the period ending March 31, 2023.

Via The Motley Fool

MannKind: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D)

June 22, 2023

From MannKind

Via GlobeNewswire

7 Overvalued Penny Stocks to Sell Before June 2023 ↗

May 28, 2023

It's time to make your exit from these overvalued penny stocks to sell, as their respective valuations are unsustainable.

Via InvestorPlace

Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical Officer

May 24, 2023

From MannKind

Via GlobeNewswire

3 Biotech Stocks to Avoid Like the Plague ↗

May 23, 2023

Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs.

Via InvestorPlace

Looking Into MannKind's Return On Capital Employed ↗

February 27, 2023

Via Benzinga

MannKind (MNKD) Q4 2022 Earnings Call Transcript ↗

February 24, 2023

MNKD earnings call for the period ending December 31, 2022.

Via The Motley Fool

MannKind Earnings Preview ↗

February 22, 2023

Via Benzinga

Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 10, 2023

Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.

Via Benzinga

Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday ↗

May 10, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference

May 10, 2023

From MannKind

Via GlobeNewswire

CORRECTION -- MannKind Corporation Reports 2023 First Quarter Financial Results

May 09, 2023

Conference Call to Begin Today at 5:00 p.m. (ET)

From MannKind

Via GlobeNewswire

Mannkind Corporation Reports 2023 First Quarter Financial Results

May 09, 2023

Conference Call to Begin Today at 5:00 p.m. (ET)

From MannKind

Via GlobeNewswire

MannKind Corporation to Hold 2023 First Quarter Financial Results Conference Call on May 9, 2023

May 02, 2023

From MannKind

Via GlobeNewswire

Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 20, 2023

Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market...

Via Benzinga

Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market ↗

April 16, 2023

One of the nice things about “boring” markets is that they do not require a lot of “rethinking of things,” and given just how resilient this market has been in the face of all that has been thrown at...

Via Talk Markets

Lauren Sabella Joins Mannkind as Executive Vice President, Chief Operating Officer

March 27, 2023

From MannKind

Via GlobeNewswire

MannKind Corporation to Participate in Oppenheimer 33rd Annual Healthcare Conference

March 07, 2023

From MannKind

Via GlobeNewswire

MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday ↗

February 27, 2023

Piper Sandler cut the price target for CS Disco, Inc. (NYSE: LAW) from $11 to $7.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Overweight to Neutral. CS Disco shares fell 1.2% to...

Via Benzinga

Kratos Defense & Security, Zeta Global, Beacon Roofing Supply And Other Big Stocks Moving Higher On Friday ↗

February 24, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results

February 23, 2023

Conference Call to Begin Today at 5:00 p.m. (ET)

From MannKind

Via GlobeNewswire

MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD Conference

February 22, 2023

From MannKind

Via GlobeNewswire

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023

February 16, 2023

From MannKind

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.